| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4013504
[patent_doc_number] => 05962660
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Sialyl Lewis X mimetics incorporating fucopeptides'
[patent_app_type] => 1
[patent_app_number] => 8/933775
[patent_app_country] => US
[patent_app_date] => 1997-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30956
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962660.pdf
[firstpage_image] =>[orig_patent_app_number] => 933775
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/933775 | Sialyl Lewis X mimetics incorporating fucopeptides | Sep 18, 1997 | Issued |
Array
(
[id] => 4360000
[patent_doc_number] => 06169075
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-02
[patent_title] => 'Cytostatic agents'
[patent_app_type] => 1
[patent_app_number] => 8/925584
[patent_app_country] => US
[patent_app_date] => 1997-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24223
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/169/06169075.pdf
[firstpage_image] =>[orig_patent_app_number] => 925584
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/925584 | Cytostatic agents | Sep 7, 1997 | Issued |
Array
(
[id] => 3999755
[patent_doc_number] => 05986108
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => '4-substitued-3-[1 or 2 amino acid residue]-azetidin-2-one derivatives useful as cysteine proteinase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/925459
[patent_app_country] => US
[patent_app_date] => 1997-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11870
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 730
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/986/05986108.pdf
[firstpage_image] =>[orig_patent_app_number] => 925459
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/925459 | 4-substitued-3-[1 or 2 amino acid residue]-azetidin-2-one derivatives useful as cysteine proteinase inhibitor | Sep 7, 1997 | Issued |
Array
(
[id] => 4221113
[patent_doc_number] => 06010871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Modification of peptide and protein'
[patent_app_type] => 1
[patent_app_number] => 8/809593
[patent_app_country] => US
[patent_app_date] => 1997-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8901
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/010/06010871.pdf
[firstpage_image] =>[orig_patent_app_number] => 809593
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/809593 | Modification of peptide and protein | Sep 7, 1997 | Issued |
Array
(
[id] => 4109168
[patent_doc_number] => 06022948
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Method of cell surface activation and inhibition'
[patent_app_type] => 1
[patent_app_number] => 8/924330
[patent_app_country] => US
[patent_app_date] => 1997-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13952
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022948.pdf
[firstpage_image] =>[orig_patent_app_number] => 924330
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/924330 | Method of cell surface activation and inhibition | Sep 4, 1997 | Issued |
Array
(
[id] => 3979460
[patent_doc_number] => 05948749
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Pharmaceutical preparations for intranasal administration'
[patent_app_type] => 1
[patent_app_number] => 8/922775
[patent_app_country] => US
[patent_app_date] => 1997-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 4653
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948749.pdf
[firstpage_image] =>[orig_patent_app_number] => 922775
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/922775 | Pharmaceutical preparations for intranasal administration | Sep 2, 1997 | Issued |
Array
(
[id] => 4158635
[patent_doc_number] => 06103870
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'CS-1 peptidomimetic, compositions and methods of using the same'
[patent_app_type] => 1
[patent_app_number] => 8/923026
[patent_app_country] => US
[patent_app_date] => 1997-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 18660
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103870.pdf
[firstpage_image] =>[orig_patent_app_number] => 923026
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/923026 | CS-1 peptidomimetic, compositions and methods of using the same | Sep 2, 1997 | Issued |
Array
(
[id] => 3988769
[patent_doc_number] => 05910569
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Iodothyronine polymers'
[patent_app_type] => 1
[patent_app_number] => 8/917098
[patent_app_country] => US
[patent_app_date] => 1997-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7971
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910569.pdf
[firstpage_image] =>[orig_patent_app_number] => 917098
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/917098 | Iodothyronine polymers | Aug 24, 1997 | Issued |
Array
(
[id] => 3789728
[patent_doc_number] => 05840850
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Dewatering gluten with anionic surfactants'
[patent_app_type] => 1
[patent_app_number] => 8/916826
[patent_app_country] => US
[patent_app_date] => 1997-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1640
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840850.pdf
[firstpage_image] =>[orig_patent_app_number] => 916826
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/916826 | Dewatering gluten with anionic surfactants | Aug 21, 1997 | Issued |
Array
(
[id] => 6519104
[patent_doc_number] => 20020192208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'NOVEL OSTEOPONTIN DERIVED CHEMOTACTIC PEPTIDES AND METHODS OF USE'
[patent_app_type] => new
[patent_app_number] => 08/918189
[patent_app_country] => US
[patent_app_date] => 1997-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12779
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192208.pdf
[firstpage_image] =>[orig_patent_app_number] => 08918189
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/918189 | Osteopontin derived chemotactic peptides and methods of use | Aug 20, 1997 | Issued |
Array
(
[id] => 3925706
[patent_doc_number] => 05952307
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Basic .alpha.-aminoalkylphosphonate derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/907840
[patent_app_country] => US
[patent_app_date] => 1997-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17611
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952307.pdf
[firstpage_image] =>[orig_patent_app_number] => 907840
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/907840 | Basic .alpha.-aminoalkylphosphonate derivatives | Aug 13, 1997 | Issued |
Array
(
[id] => 3975466
[patent_doc_number] => 05916877
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Fluorescent 1-peptidylaminoalkanephosphonate derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/911380
[patent_app_country] => US
[patent_app_date] => 1997-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5594
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916877.pdf
[firstpage_image] =>[orig_patent_app_number] => 911380
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/911380 | Fluorescent 1-peptidylaminoalkanephosphonate derivatives | Aug 13, 1997 | Issued |
Array
(
[id] => 4016121
[patent_doc_number] => 05880258
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Anticoagulant hirudin variants and methods for their production'
[patent_app_type] => 1
[patent_app_number] => 8/909735
[patent_app_country] => US
[patent_app_date] => 1997-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 15352
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880258.pdf
[firstpage_image] =>[orig_patent_app_number] => 909735
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909735 | Anticoagulant hirudin variants and methods for their production | Aug 11, 1997 | Issued |
Array
(
[id] => 3949574
[patent_doc_number] => 05955435
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Peptidyl compounds having MMP and TNF inhibitory activity'
[patent_app_type] => 1
[patent_app_number] => 8/908990
[patent_app_country] => US
[patent_app_date] => 1997-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8033
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 903
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955435.pdf
[firstpage_image] =>[orig_patent_app_number] => 908990
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/908990 | Peptidyl compounds having MMP and TNF inhibitory activity | Aug 7, 1997 | Issued |
Array
(
[id] => 4324166
[patent_doc_number] => 06331610
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin'
[patent_app_type] => 1
[patent_app_number] => 8/908371
[patent_app_country] => US
[patent_app_date] => 1997-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 13
[patent_no_of_words] => 10646
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331610.pdf
[firstpage_image] =>[orig_patent_app_number] => 908371
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/908371 | Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin | Aug 6, 1997 | Issued |
| 08/875669 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR, SIDE EFFECT- REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST AND DIURETIC | Jul 31, 1997 | Abandoned |
Array
(
[id] => 4038059
[patent_doc_number] => 05856439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same'
[patent_app_type] => 1
[patent_app_number] => 8/875752
[patent_app_country] => US
[patent_app_date] => 1997-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2992
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856439.pdf
[firstpage_image] =>[orig_patent_app_number] => 875752
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/875752 | Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same | Jul 31, 1997 | Issued |
| 08/904416 | COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Jul 30, 1997 | Pending |
| 08/920353 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Jul 30, 1997 | Pending |
| 08/904417 | DIPEPTIDE AND RELATED COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Jul 30, 1997 | Pending |